Moscatilin repressed lipopolysaccharide-induced hif-1α accumulation and NF-κB activation in murine raw264.7 cells

Shock

Volumn 33, Issue 1, 2010, Pages 70-75

  Liu, Yi Nan ^a   Pan, Shiow Lin ^a   Peng, Chieh Yu ^a   Huang, Der Yi ^a   Guh, Jih Hwa ^a   Chen, Chien Chih ^b   Shen, Chien Chang ^b   Teng, Che Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

HIF 1 ; Macrophage; Moscatilin; NF B

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BIBENZYL DERIVATIVE; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; HERBACEOUS AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MOSCATILIN; PLANT EXTRACT; RNA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HERB; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BENZYL COMPOUNDS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 73849126770     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181a7ff4a     Document Type: Article

References (32)

1. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, et al.: HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645-657, 2003.
2. Lu YC, Yeh WC, Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine 42:145-151, 2008.
3. Leon CG, Tory R, Jia J, Sivak O, Wasan KM: Discovery and development of Toll-like receptor 4 (TLR4) antagonists: A new paradigm for treating sepsis and other diseases. Pharm Res 25:1751-1761, 2008.
4. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227-242, 1990.
5. Draing C, Sigel S, Deininger S, Traub S, Munke R, Mayer C, Hareng L, Hartung T, von Aulock S, Hermann C: Cytokine induction by Gram-positive bacteria. Immunobiology 213:285-296, 2008.
6. Perkins ND: Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8:49-62, 2007.
7. Dos SS, Delattre AI, De Longueville F, Bult H, Raes M: Gene expression profiling of LPS-stimulated murine macrophages and role of the NF-kappaB and PI3K/mTOR signaling pathways. Ann N Y Acad Sci 1096:70-77, 2007.
8. Blouin CC, Page EL, Soucy GM, Richard DE: Hypoxic gene activation by lipopolysaccharide in macrophages: Implication of hypoxia-inducible factor 1alpha. Blood 103:1124-1130, 2004.
9. Nishi K, Oda T, Takabuchi S, Oda S, Fukuda K, Adachi T, Semenza GL, Shingu K, Hirota K: LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen speciesYdependent manner. Antioxid Redox Signal 10:983-995, 2008.
10. Harris AL: HypoxiaVa key regulatory factor in tumour growth. Nat Rev Cancer 2:38-47, 2002.
11. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732, 2003.
12. Ho CK, Chen CC: Moscatilin from the orchid Dendrobrium loddigesii is a potential anticancer agent. Cancer Invest 21:729-736, 2003.
13. Chen TH, Pan SL, Guh JH, Liao CH, Huang DY, Chen CC, Teng CM: Moscatilin induces apoptosis in human colorectal cancer cells: A crucial role of c-Jun NH2-terminal protein kinase activation caused by tubulin depolymerization and DNA damage. Clin Cancer Res 14:4250-4258, 2008.
14. Chen CC, Wu LG, Ko FN, Teng CM: Antiplatelet aggregation principles of Dendrobium loddigesii. J Nat Prod 57:1271-1274, 1994.
15. Oda T, Hirota K, Nishi K, Takabuchi S, Oda S, Yamada H, Arai T, Fukuda K, Kita T, Adachi T, et al.: Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am J Physiol Cell Physiol 291: C104-C113, 2006.
16. Shin EM, Zhou HY, Guo LY, Kim JA, Lee SH, Merfort I, Kang SS, Kim HS, Kim S, Kim YS: Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis (Leguminosae) in LPS-induced RAW264.7 macrophages. Int Immunopharmacol 8(11):1524-1532, 2008.
17. Sarkar D, Saha P, Gamre S, Bhattacharjee S, Hariharan C, Ganguly S, Sen R, Mandal G, Chattopadhyay S, Majumdar S, et al.: Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappaB pathway. Int Immunopharmacol 8:1264-1271, 2008.
18. Walmsley SR, Cadwallader KA, Chilvers ER: The role of HIF-1alpha in myeloid cell inflammation. Trends Immunol 26:434-439, 2005.
19. Karhausen J, Haase VH, Colgan SP: Inflammatory hypoxia: Role of hypoxiainducible factor. Cell Cycle 4:256-258, 2005.
20. Scortegagna M, Cataisson C, Martin RJ, Hicklin DJ, Schreiber RD, Yuspa SH, Arbeit JM: HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 111: 3343-3354, 2008.
21. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L: IL-1betaYmediated upregulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17: 2115-2117, 2003.
22. Hollander AP, Corke KP, Freemont AJ, Lewis CE: Expression of hypoxiainducible factor 1alpha by macrophages in the rheumatoid synovium: Implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 44:1540-1544, 2001.
23. Wang MT, Honn KV, Nie D: Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26:525-534, 2007.
24. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350, 1997.
25. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M: NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453:807-811, 2008.
26. Gorlach A, Bonello S: The cross-talk between NF-kappaB and HIF-1: Further evidence for a significant liaison. Biochem J 412:e17-e19, 2008.
27. Mi Z, Rapisarda A, Taylor L, Brooks A, Creighton-Gutteridge M, Melillo G, Varesio L: Synergystic induction of HIF-1alpha transcriptional activity by hypoxia and lipopolysaccharide in macrophages. Cell Cycle 7:232-241, 2008.
28. Frede S, Stockmann C, Freitag P, Fandrey J: Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NFkappaB. Biochem J 396:517-527, 2006.
29. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, Gorlach A: Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27:755-761, 2007.
30. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, Gorlach A: Hypoxia up-regulates hypoxia-inducible factorY1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18:4691-4697, 2007.
31. Pan SL, Guh JH, Peng CY, Chang YL, Cheng FC, Chang JH, Kuo SC, Lee FY, Teng CM: A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models. Thromb Haemost 93:940-948, 2005.
32. Sun HL, Liu YN, Huang YT, Pan SL, Huang DY, Guh JH, Lee FY, Kuo SC, Teng CM: YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 26:3941-3951, 2007.